CD276 and neuroblastoma: To assess the cytotoxicity and immunogenicity correlates, we measured the viability of the cells, the induction of ICD, and the phenotypic changes (i.e., expression of costimulatory molecules, immune checkpoint molecules, major histocompatibility complexes, an NK cell-activating ligand, and a neuroblastoma-associated antigen) resulting from each thermal dose.